Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Newborns and children from birth to 7 years old who have one of these eye conditions: anophthalmia (missing one or both eyes), microphthalmia (abnormally small eyes), aniridia (missing or underdeveloped iris), or anterior segment dysgenesis (a problem with the front part of the eye), where parents have reviewed the risks and benefits and agreed to participate
- Children aged 8 and older with the same eye conditions listed above, where parents have reviewed the risks and benefits and agreed to participate
- Adults who have one of the eye conditions listed above and are able to review the risks and benefits and agree to participate themselves
- Adults with the eye conditions listed above who have a legal guardian, where the guardian has reviewed the risks and benefits and agreed to participate on their behalf
- Adult parents of a child already taking part in the study who are willing to take part in a separate genetics study (looking at how the condition may be inherited)
- Pregnant women
- People enrolled through French trial centres who are from another country, provided they agree to cover all medical costs themselves
- People covered by the French national health insurance ("Régime National d'Assurance Maladie")
Who may not be able to join:
- There are no listed exclusion criteria for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nicolas NC CHASSAING, Dr, Centre de référence des maladies ophtalmologiques rares
Phone: 0033 5 61 77 90 55
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Visual acuity including distance and near vision, completed if necessary by a low vision evaluation with ETDRS scale, will be conducted with refraction under cycloplegia.; An accurate description of the binocular vision by orthoptists; Slit lamp examination and fundus with imaging will be useful to specify the disease.; An ultrasound measurement will evaluate axial length of eyeball.; Some imaging ocular techniques as videotopography (Pentacam); Some imaging ocular techniques as ultrabiomicroscopy to evaluate anterior segment; Some imaging ocular techniques as macular OCT (spectral-domain opti...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.